Cara Therapeutics Statistics
Total Valuation
CARA has a market cap or net worth of $16.73 million. The enterprise value is $18.69 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CARA has 54.85 million shares outstanding. The number of shares has increased by 1.28% in one year.
| Current Share Class | 54.85M |
| Shares Outstanding | 54.85M |
| Shares Change (YoY) | +1.28% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 1.22% |
| Owned by Institutions (%) | 26.66% |
| Float | 46.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.92 |
| Forward PS | 3.81 |
| PB Ratio | 23.66 |
| P/TBV Ratio | 23.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.77, with a Debt / Equity ratio of 62.23.
| Current Ratio | 4.77 |
| Quick Ratio | 4.32 |
| Debt / Equity | 62.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.76 |
Financial Efficiency
Return on equity (ROE) is -221.25% and return on invested capital (ROIC) is -74.81%.
| Return on Equity (ROE) | -221.25% |
| Return on Assets (ROA) | -61.79% |
| Return on Capital (ROIC) | -74.81% |
| Revenue Per Employee | $157,927 |
| Profits Per Employee | -$1.74M |
| Employee Count | 55 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 16.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.27% in the last 52 weeks. The beta is 0.68, so CARA's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -72.27% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.51 |
| Relative Strength Index (RSI) | 51.24 |
| Average Volume (20 Days) | 918,209 |
Short Selling Information
The latest short interest is 942,535, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 942,535 |
| Short Previous Month | 609,721 |
| Short % of Shares Out | 1.72% |
| Short % of Float | 2.01% |
| Short Ratio (days to cover) | 2.20 |
Income Statement
In the last 12 months, CARA had revenue of $8.69 million and -$95.53 million in losses. Loss per share was -$1.75.
| Revenue | 8.69M |
| Gross Profit | -22.90M |
| Operating Income | -82.39M |
| Pretax Income | -122.54M |
| Net Income | -95.53M |
| EBITDA | -82.11M |
| EBIT | -82.39M |
| Loss Per Share | -$1.75 |
Full Income StatementBalance Sheet
The company has $42.04 million in cash and $44.00 million in debt, giving a net cash position of -$1.96 million or -$0.04 per share.
| Cash & Cash Equivalents | 42.04M |
| Total Debt | 44.00M |
| Net Cash | -1.96M |
| Net Cash Per Share | -$0.04 |
| Equity (Book Value) | 707,000 |
| Book Value Per Share | 0.01 |
| Working Capital | 37.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$74.24 million and capital expenditures -$3.10 million, giving a free cash flow of -$77.34 million.
| Operating Cash Flow | -74.24M |
| Capital Expenditures | -3.10M |
| Free Cash Flow | -77.34M |
| FCF Per Share | -$1.41 |
Full Cash Flow StatementMargins
| Gross Margin | -263.62% |
| Operating Margin | -948.50% |
| Pretax Margin | -1,099.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -537.99% |